ixlayer
ixlayer is a private, San Francisco-based healthcare technology company that provides a cloud-based direct-to-patient platform for biopharma, integrating telehealth, lab testing, prescription fulfillment, and AI-driven patient engagement into white-labeled care programs. It serves enterprise pharmaceutical clients including Sanofi, Regeneron, and Vertex Pharmaceuticals.
- Company typePrivate
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What ixlayer does
ixlayer is a private, venture-backed healthcare technology company founded in 2017 and headquartered in San Francisco that operates a cloud-based direct-to-patient (DTP) platform purpose-built for the biopharma industry. The company sells to pharmaceutical brand teams, commercial innovation units, and marketing leadership, enabling them to deploy white-labeled, compliant patient engagement programs that span condition screening, at-home and service-center lab testing, telehealth consultations, prescription fulfillment, benefits verification, and care continuity. The core platform, ixEngage, unifies seven service modules — Virtual Patient Experience, Telehealth, Lab Testing, Prescription Fulfillment, Benefits Verification/Claims/Payment, Connected Care, and ixAI Patient Concierge — over a SOC 2 Type 2, HIPAA, HITRUST, and DOD IL5 Gov Cloud infrastructure integrated with CLIA/CAP certified labs and multiple independent telehealth networks. The ixAI Patient Concierge layer adds a conversational Co-Pilot for multilingual patient onboarding and an Agent that autonomously places outbound phone calls to schedule appointments, verify insurance, and retrieve prescription refills.
The company makes money through enterprise platform licensing (annual subscriptions configured per therapeutic area, program scope, and integration complexity) combined with per-transaction fees for telehealth consultations, lab tests, prescription fulfillments, and benefits verification. Go-to-market is sales-led with dedicated enterprise ABM targeting top-25 biopharma accounts, supported by thought leadership content, proprietary research surveys (ixInsights with Ipsos, DHC Group, Sermo), and presence at industry events (Fierce Pharma Week, Digital Pharma East). The company claims over 1,100 nationwide programs powered, more than 4 million patient care journeys activated, and named enterprise customers including Sanofi, Regeneron, Vertex Pharmaceuticals, UCB, AstraZeneca, UCSF, Illumina, Eurofins, Charles River, Bio-Techne, Avera, and Hims & Hers. Recent strategic emphasis has shifted from white-label infrastructure toward co-developed branded telehealth products such as SkinLink.us (dermatology, with Sanofi/Regeneron) and Informed Pain Care (acute pain, with Vertex), suggesting a hybrid revenue model that combines platform licensing with shared-product economics. The company is led by co-founder and CEO Pouria Sanae and co-founder and COO Poorya Sabounchi, PhD.
ixlayer firmographics
Firmographics- Name
- ixlayer
- Legal name
- IX Layer Inc.
- Website
- https://ixlayer.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ixlayer is a private, San Francisco-based healthcare technology company that provides a cloud-based direct-to-patient platform for biopharma, integrating telehealth, lab testing, prescription fulfillment, and AI-driven patient engagement into white-labeled care programs. It serves enterprise pharmaceutical clients including Sanofi, Regeneron, and Vertex Pharmaceuticals.
- Ownership category
- akta.pro rank
ixlayer industry classification
Industry- Product category
- Biopharma Direct-to-Patient Healthcare Platform
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Ambulatory Health Care Services (621)
- SIC
- Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Care Navigation, Referral & Digital Front Door Platforms (HLALABAH)
- akta.pro secondary industries
- Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ), Diagnostic/Lab & Imaging Referral Marketplaces (HLALALAG)
Keywords
Where ixlayer is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ixlayer business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations, Supply Chain
Revenue model
- Platform/SaaS Licensing: ixlayer provides its ixEngage platform as a licensed service to biopharma companies. The platform supports multiple therapeutic areas and patient journeys, with pricing based on program scope, volume, and services utilized
- Transaction-Based Services: Revenue generated per patient journey or service transaction including telehealth consultations, lab tests, prescription fulfillments, and benefits verification. Volume-based pricing tied to number of patient interactions and completions
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise platform licensing with configurable service modules |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
ixlayer product offering
Product offeringCore offering
ixlayer sells the ixEngage platform, a cloud-based direct-to-patient infrastructure that biopharma companies license to launch white-labeled programs combining telehealth, lab testing, prescription fulfillment, benefits verification, and connected care for patients with chronic conditions. The platform is sold as an enterprise SaaS subscription with configurable modules and per-transaction services, and is also deployed as branded sub-products such as SkinLink.us and Informed Pain Care for specific therapeutic areas.
Product overview
ixlayer is a cloud-based direct-to-patient (DTP) healthcare platform built for biopharma. The core offering is ixEngage, a unified platform that integrates seven service modules: Virtual Patient Experience, Telehealth, Lab Testing, Prescription Fulfillment, Benefits Verification/Claims/Payment, Connected Care, and ixAI Patient Concierge. The ixAI Patient Concierge module provides AI-powered patient engagement via Co-Pilot (AI-guided onboarding via voice/text) and Agent (autonomous outbound calling for appointment scheduling and Rx refills). ixlayer also operates sub-brand telehealth products including SkinLink.us (dermatology, with Sanofi/Regeneron) and Informed Pain Care (acute pain, with Vertex). The platform supports multiple therapeutic areas with white-labeled patient experiences configurable per program.
Differentiator
Problem solved
Functional benefit
Brands
- ixEngage: ixlayer's direct-to-patient platform that seamlessly integrates remote testing, national diagnostic-lab networks, independent telehealth providers, and pharmacies for personalized diagnostic journeys.
- ixAI Patient Concierge
- SkinLink.us
- Informed Pain Care
Products and services
- ixEngage White-labeled direct-to-patient platform for biopharma integrating virtual patient experience, telehealth, lab testing, prescription fulfillment, benefits verification, claims/payment, and connected care into a single configurable stack across multiple therapeutic areas.
- ixAI Patient Concierge AI-powered patient engagement layer combining a Co-Pilot for guided onboarding via natural voice or text with an Agent that places autonomous phone calls to schedule appointments, verify insurance, and handle prescription refills in 10+ languages.
- SkinLink.us Telehealth platform for chronic skin conditions developed with Sanofi and Regeneron, providing virtual evaluations, diagnosis, image-based assessments, and prescription fulfillment for patients in all 50 U.S. states.
- Informed Pain Care Telehealth platform for acute pain evaluation developed with Vertex Pharmaceuticals, connecting patients to licensed clinicians for symptom screening, evaluation, and access to non-opioid treatment options with flexible pharmacy fulfillment.
Quantifiable outcome
- 85% of completed patient appointments result in a prescription
- +5 more outcomes
Companies that use ixlayer
Customer profileNamed customers14 records
Segments3 records
Ideal customer profiles2 records
ixlayer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability6 records
Feature5 records
ixlayer partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and supporting.
- Vertex PharmaceuticalscoreDeveloped Informed Pain Care platform in collaboration with Vertex Pharmaceuticals - ixlayer's first direct-to-patient telehealth offering and Vertex's entry into the nonsurgical acute pain telehealth space. The platform connects patients to licensed healthcare professionals for evaluation and access to treatment options including Vertex's non-opioid therapies.
- The Dot CorpsupportingPartnership to enhance supply chain, kit design, and fulfillment for direct-to-patient healthcare programs. Aims to improve speed, scalability, and quality of at-home diagnostics and patient onboarding services.
- SanoficoreCollaboration on SkinLink.us platform designed to improve access to dermatological care for patients with chronic skin conditions across all 50 U.S. states. Platform offers virtual evaluations, diagnosis, and treatment options in collaboration with Sanofi and Regeneron.
- RegeneroncoreCollaboration on SkinLink.us platform for dermatological care access. Platform developed with Sanofi and Regeneron for patients with chronic skin conditions including Atopic Dermatitis.
- IpsossupportingPartnership for ixInsights 2025 research study on consumer expectations for digital health and pharma's role in patient experience. Survey of 414 patients with chronic conditions conducted by Ipsos.
- DHC GroupsupportingResearch partnership conducting surveys of pharmaceutical executives and healthcare providers on DTP trends, best practices, and implementation considerations.
- SermosupportingPartnership for physician survey on attitudes toward at-home diagnostic testing. Survey of 140+ physicians across multiple specialties conducted with DHC and Sermo.
- OptumRxsupportingPharmacy benefit management partner integrated into platform. PreCheck My Script capability enables real-time benefit verification for integrated DTP workflows.
- Amazon PharmacysupportingPharmacy fulfillment partner integrated into platform for prescription delivery services within direct-to-patient workflows.
- Gift HealthsupportingPharmacy services partner integrated into platform for prescription routing and fulfillment.
- Multiple Telehealth NetworkscorePlatform integrates multiple independent telehealth provider networks to ensure patient choice and compliance. Rules-based routing connects patients to appropriate care providers without preferential steering.
- CLIA/CAP Certified LabscoreNetwork of clinical laboratory improvement amendment certified and college of american pathologists accredited laboratories supporting at-home and service center testing options.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
ixlayer competitors and assessment
Company assessmentDirect peers
- OptimizeRx: OptimizeRx operates a direct-to-patient and point-of-care messaging platform connecting pharma brands with patients and HCPs. It is the closest public comparable to ixlayer's pharma-sponsored DTP journey model, with overlapping advertiser and brand-sponsor buyer base.
- ConnectiveRx: ConnectiveRx delivers patient access, affordability, and adherence programs for pharma, including telehealth, hub services, and benefits verification. Comparable to ixlayer's benefits verification, prescription fulfillment, and patient support services layered on top of pharma sponsorship.
- PatientPoint: PatientPoint delivers point-of-care patient engagement content and programs sponsored by pharma, primarily in physician offices. Comparable as a pharma-sponsored patient engagement platform, though ixlayer's telehealth/lab/Rx integration goes further along the journey.
- Carenet Health: Carenet Health provides care navigation, clinical support, and patient engagement services for health plans, providers, and pharma. Overlaps with ixlayer in benefits navigation, telehealth coordination, and care concierge capabilities.
Broad incumbents
- Veeva Systems: Veeva is the dominant SaaS platform for life sciences commercial, medical, and clinical operations. While Veeva does not offer a consumer-facing DTP layer, its CRM, Vault, and commercial data assets position it as a potential competitor or partner for biopharma CX programs.
- IQVIA: IQVIA combines commercial analytics, real-world data, and patient engagement services for life sciences. Its broader portfolio overlaps with ixlayer in pharma-sponsored patient engagement and outcomes analytics, though IQVIA is not purpose-built for the DTP journey layer.
- Surescripts: Surescripts operates the dominant e-prescription and clinical information network in the U.S., sitting between pharmacies, prescribers, and PBMs. It is a partner/integration for ixlayer's prescription fulfillment and benefits verification modules and a potential broader platform competitor.
- Included Health: Included Health (Doctor On Demand) offers virtual primary care, behavioral health, and care navigation, primarily employer- and payer-sponsored. Comparable in telehealth and care navigation, but its buyer is the payer/employer rather than the pharma brand.
Emerging players
- Upfront Healthcare: Upfront Healthcare provides patient engagement and digital front-door services for health systems. Compares to ixlayer in care navigation and patient onboarding, though anchored to provider systems rather than pharma sponsors.
Others
- Hims & Hers Health: Hims & Hers operates a direct-to-consumer telehealth and pharmacy platform. Listed as a partner of ixlayer and a useful comparable for consumer-facing telehealth/Rx delivery economics, but its business model is consumer-paid rather than pharma-sponsored.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
ixlayer social profiles
Digital presenceixlayer compliance and trust
Trust signalCompliance4 records
ixlayer financial estimates
Financial estimateRevenue estimate
Valuation estimate
ixlayer leadership team
Management profileNumber of profiles
Profiles11 records
ixlayer funding detail
Funding detailFunding overview
Funding rounds3 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ixlayer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ixlayer
What does ixlayer do?
ixlayer sells the ixEngage platform, a cloud-based direct-to-patient infrastructure that biopharma companies license to launch white-labeled programs combining telehealth, lab testing, prescription fulfillment, benefits verification, and connected care for patients with chronic conditions. The platform is sold as an enterprise SaaS subscription with configurable modules and per-transaction services, and is also deployed as branded sub-products such as SkinLink.us and Informed Pain Care for specific therapeutic areas.
Is ixlayer a public or private company?
ixlayer is a private company. It is classified as venture growth investor backed and is currently operating.
When was ixlayer founded?
ixlayer was founded in 2017. It employs 51 to 100 people.
Where is ixlayer based?
ixlayer is headquartered in San Francisco, United States, in the North America region.
How does ixlayer make money?
Two revenue lines are on record. Platform/SaaS Licensing is the primary driver. The others are transaction-Based Services.
Who are ixlayer's main competitors?
Direct peers on record are OptimizeRx, ConnectiveRx, PatientPoint and Carenet Health. Broad incumbents are Veeva Systems, IQVIA, Surescripts and Included Health. Upfront Healthcare is listed as an emerging player. Hims & Hers Health is listed as an others.
Does ixlayer have an API?
No public API is recorded for ixlayer.
What industry is ixlayer in?
ixlayer's product category is Biopharma Direct-to-Patient Healthcare Platform. Its primary akta.pro industry code is HLALABAH, Care Navigation, Referral & Digital Front Door Platforms, with a secondary code of HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated). Its NAICS code is 62151 and its SIC code is 8071.